Zanubrutinib and Venetoclax in CLL (ZANU-VEN) — StellaPhase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.
Trial locations(4 sites)
United States
New England Cancer Specialists, Scarborough, Maine Beth Israel Deaconess Medical Center, Boston, Massachusetts Dana-Farber Cancer Institute, Boston, Massachusetts South Shore Hospital, South Weymouth, Massachusetts Last updated December 2025